Our lab is working to advance biotechnology and medicine by combining organic chemistry, chemical biology, and materials chemistry. Current efforts are focused on developing effective treatments and detection tools derived from small molecules and nucleic acids in the fight against various critical diseases that affect large human populations. Additionally, we are developing highly adaptable point-of-care technologies using surface and interface chemistry. Other major research involves lipid biochemistry with an emphasis on finding new and biochemically advanced functions of cell membranes.
Lab members have the opportunity to learn a wide array of experimental techniques and carry out both fundamental and applied research in a collaborative environment.
The lab receives Research Grants Program award from the New Jersey Health Foundation, which will support our studies on the prevention and eradication of biofilms.
The Materials Research Team including the Izgu Lab receives funding from Rutgers to engineer co-stimulatory protocells as therapeutic agents against cancer.
The next-generation material surface functionalization technology that Zhaojun (John) Jia is developing leads to a provisional patent. Congrats John, and thanks to the Rutgers ORED for supporting our technology.
A team of Rutgers faculty including E.C. Izgu receives funding from the Chancellor's Office of Rutgers for the in vitro design and in vivo implementation of synthetic cells.
The lab receives the Charles and Johanna Busch Biomedical Grant Award. Thanks to the Rutgers, Office of Research and Economic Development (ORED) for supporting our research.
E.C. Izgu receives the 2019 American Cancer Society Institutional Research Grant Early Investigator Award. This award is also complemented with additional funding from the Cancer Institute of New Jersey. Thanks to ACS and CINJ for supporting our lab.